HigherHighs
RankingLoading... stocks
USA
NASDAQ
Healthcare
Biotechnology
DYN (USA) - Dyne Therapeutics Inc
1W
1M
3M
6M
1Y
2Y
5Y
All
ABOUT Dyne Therapeutics Inc
Dyne Therapeutics, Inc., a clinical-stage muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.